Ownership history in JOHNSON & JOHNSON · 10 quarters on record
This page tracks every 13F SEC filing in which JOHNSON & JOHNSON reported a position in Nanobiotix S.A. (NBTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 5,623,816 | — | 0% | 23.44% | $130.0M | $23.12 |
| 2025 Q3 | UNCHANGED | 5,623,816 | — | 0% | 21.09% | $106.2M | $18.89 |
| 2025 Q2 | UNCHANGED | 5,623,816 | — | 0% | 7.62% | $25.5M | $4.73 |
| 2025 Q1 | UNCHANGED | 5,623,816 | — | 0% | 5.89% | $20.1M | $3.58 |
| 2024 Q4 | UNCHANGED | 5,623,816 | — | 0% | 4.18% | $16.1M | $2.87 |
| 2024 Q3 | UNCHANGED | 5,623,816 | — | 0% | 7.57% | $32.3M | $5.75 |
| 2024 Q2 | UNCHANGED | 5,623,816 | — | 0% | 7.02% | $28.1M | $5.00 |
| 2024 Q1 | UNCHANGED | 5,623,816 | — | 0% | 0.83% | $36.6M | $6.50 |
| 2023 Q4 | ADDED | 5,623,816 | +4,664,179 | +486.0% | 0.93% | $40.9M | $7.28 |
| 2023 Q3 | INITIATED | 959,637 | — | — | 3.09% | $8.4M | — |
As of 2025 Q4 — sorted by position size